A lumbar puncture (LP) was performed in 23 patients; 15 of the CSF results were abnormal (pleocytosis, n = 12; elevated protein, n = 12; both, n = 9); 3 LPs were traumatic, as indicated by elevated CSF red blood cell counts.
A total of 13 patients required endotracheal intubation and ventilation. Twelve patients had circulatory compromise, of whom 11 required inotropic support; 3 additionally required extracorporeal membrane oxygenation (ECMO). Three patients requiring inotropic support had to be treated with dialysis as a result of acute renal failure.
Nine patients fulfilled the definition for sepsis. Three patients had circulatory compromise, 1 of whom needed ventilation. The ALT concentration was mildly elevated (46 IU/L) in 1 patient. In 6 out of 8 cases who had undergone an LP CSF WBC count and/or protein concentration were elevated, but the enterovirus PCR performed on CSF was negative in all cases and the patients did not fulfill the criteria for encephalitis. The causative genotypes in those 6 cases comprised the following: coxsackie A16 (CA16), coxsackie B1 (CB1), echovirus 5 (E5), echovirus 16 (E16); 2 were not typed. One 9-day-old infant with enterovirus sepsis had an out-of-hospital arrest. He had focal seizures with secondary generalization on arrival in the emergency department, had circulatory compromise and required endotracheal intubation and ventilation. He died on the pediatric intensive care unit on day 6 of his admission. The postmortem examination did not identify a definite cause of death. A nontypable enterovirus was detected on a throat swab.
Of the 8 patients with myocarditis 1 presented with recurrent supraventricular tachycardia and pericardial effusion; the remaining 7 (88%) presented with circulatory compromise and required intubation and ventilation. The ALT concentration was elevated in 6 patients (75%), ranging from 42 to 748 IU/L. An LP was performed in 2 patients; both were traumatic. In 1 patient with myocarditis enterovirus 71 (EV71) was detected on a rectal swab and coxsackie B3 (CB3) was detected on a throat swab; the blood and CSF samples were also positive for enterovirus (not typed). This patient was severely unwell at presentation, and required ECMO support. Two patients with myocarditis, aged 6 and 7 days respectively at presentation, died despite ECMO support; the causative genotypes were CB3 and coxsackie B4 (CB4). At follow-up, 2 of the 6 survivors continued to have significantly reduced myocardial function; the remaining 4 made a full recovery.
Eight patients fulfilled the criteria for enterovirus meningitis; as per the case definition, in all 8 cases enterovirus was detected in the CSF. One of these patients required intubation and ventilation, as well as inotropic support. None of these cases had abnormal focal neurological signs or seizures. The ALT concentration was normal in all patients. CSF results were abnormal in 7 patients and normal in 1 patient. None of these patients had evidence of neurological sequelae at discharge.
Five children fulfilled the study criteria for encephalitis, of whom 2 presented with focal seizures. CSF protein concentration and WBC results were normal in 3 and abnormal in 2 patients. In 1 case, the CSF PCR was positive for enterovirus. Computer tomography imaging of this patient showed bithalamic low attenuation signals consistent with encephalitis. The ALT concentration was abnormal in 1 of these patients (539 IU/L). One patient admitted after an out-of-hospital cardiac arrest was subsequently diagnosed with encephalitis based on electroencephalogram abnormalities. Long-term sequelae at follow-up in the encephalitis group comprised developmental delay (n = 1), reduced visual fields (n = 1) and persistent seizure disorder with focal features (n = 1).
Duration of Hospital Stay and Survival
The median duration of hospital stay was significantly different between the 4 groups (Kruskal–Wallis P = 0.005). Patients with encephalitis had a median hospital stay of 16 days, while the duration of hospital stay in myocarditis, sepsis and meningitis patients was 9, 6 and 3 days, respectively. The overall mortality among the study population across all clinical phenotypes was 10% (3/30).
This study demonstrates the spectrum of severe enterovirus disease in children hospitalized at a tertiary pediatric hospital serving a large regional population. The data show that enterovirus infections cause significant morbidity and mortality. Although this study a priori only included patients requiring admission to hospital, it is striking that the mortality in this cohort was substantial despite the availability of high-level PICU support, including ECMO. Also, it is notable that a considerable proportion of the survivors in the myocarditis group had persistently reduced myocardial function, which is concordant with the findings of a recent study from The Netherlands.23
Our data show that children presenting with enterovirus sepsis or myocarditis are significantly younger on average than those presenting with enterovirus CNS disease. Considering that almost all cases with sepsis and myocarditis (15 out of 17 patients) in this study presented within the first 3 months of life, we believe that all young infants presenting with fever and circulatory compromise or other symptoms consistent with sepsis should be tested for enterovirus infection. Interestingly, we found that only in a relatively small proportion of cases (11%) in the sepsis group enterovirus could be detected in blood, while rectal swabs had a much higher yield (67%) in this group. This is consistent with observations from a previous study in young infants with enterovirus sepsis, which found that real-time PCR cycle threshold values are generally considerably lower in fecal samples than in blood samples.24 Timely testing for enteroviruses can help to inform management decisions, including the consideration to discontinue broad-spectrum antibiotics in these patients. Unfortunately, current treatment options for enterovirus infections are limited as there are no licensed antiviral treatment options.2,25,26 Also, the use of intravenous immunoglobulin for severe enterovirus infections, including myocarditis, remains controversial as the currently available data are insufficiently robust.2
The results also highlight that there is considerable diversity in the causative genotypes in each of the clinical phenotypes. However, there was a relative predominance of echoviruses in patients with meningitis, and some predominance of coxsackie B viruses in the myocarditis group. The latter association has been described in previous publications.4,23,27,28
Earlier studies have shown that the predominant enterovirus serotypes within populations change continuously over time.3,14,15 In our study, we found that coxsackie A viruses, coxsackie B viruses and echoviruses accounted for similar proportions of the severe enterovirus infections. This contrasts with data from an epidemiological study conducted in England and Wales that reported data from 1975 to 1994, in which 61% of the culture-confirmed enterovirus isolates were found to be echoviruses, 10% coxsackie A viruses and 29% coxsackie B viruses.29 A recently published study providing laboratory data from the national reference laboratory in England and Wales from the period 2000 to 2011 reported similar proportions, with echoviruses accounting for 55%, coxsackie A viruses for 5%, and coxsackie B viruses for 23% of the enterovirus strains for which typing result were available.16 Comparing our data to those national data it appears that cases with coxsackie A virus infection were relatively overrepresented in our cohort, although the significance of this remains uncertain. However, our data show that this was not due to a single coxsackie A virus serotype with particular virulence.
In one patient with encephalitis two potentially causative organisms, an enterovirus and an adenovirus, were detected in respiratory secretions. The cause of the CNS disease in this case therefore remains uncertain. Published data, including large-scale epidemiological studies, suggest that enterovirus-related CNS disease is far more common than adenovirus-related CNS disease.30 Also, in contrast to enteroviruses, adenoviruses have a propensity to persist in lymphoepithelial tissues and detection of this organism may therefore merely have reflected past infection in this patient.
Two additional findings related to CNS disease are intriguing and warrant further investigation. First, our data show that in some patients with clinical features of meningitis in whom enterovirus is present in the CSF, CSF WBC and protein concentrations are within normal limits. This highlights that an unremarkable CSF analysis does not rule out enterovirus meningitis, an observation that is consistent with a recent small study from Scotland, which focused exclusively on children with enterovirus sepsis and CNS disease.9 Second, our results show that in a considerable proportion of cases with enterovirus infections who present with sepsis-like symptoms (and without clinically apparent meningitis), the CSF analysis is abnormal.
The main limitation of our study lies in the comparatively small sample size, resulting from the fact that the study was conducted at a single healthcare institution. However, this is the first description of predominant causative enteroviruses causing severe neonatal and pediatric disease in England in more than a decade. It remains uncertain whether our data can be extrapolated to the rest of the United Kingdom. Consequently, a multicenter study investigating the correlation between clinical phenotypes and causative enterovirus genotypes would be desirable. Our study was deliberately designed to describe severe enterovirus disease in children admitted to a tertiary children’s hospital, and therefore does not provide data on “milder” forms of enterovirus disease that are primarily encountered in the community setting.
Enterovirus infections, particularly enterovirus myocarditis and encephalitis, can result in significant morbidity and mortality. Even with high-level PICU support available, a substantial proportion of patients with severe enterovirus disease have a fatal outcome. In addition, our data show that there is considerable diversity in the enterovirus genotypes causing severe disease in the South of England, with coxsackie A virus-related disease being relatively overrepresented when compared with national epidemiological data. Furthermore, the results highlight that there are currently no strong associations between clinical phenotypes and particular causative enterovirus genotypes in the South of England.
1. Pallansch MR, Oberste MS, Whitton JL. Knipe D, Howley P. Enteroviruses: polioviruses, coxsakieviruses, echoviruses, and newer enteroviruses. Fields Virology. 2013:6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 490–530.
2. Tebruegge M, Curtis N. Enterovirus infections in neonates. Semin Fetal Neonatal Med. 2009;14:222–227.
3. Centers for Disease Control and Prevention (CDC). Nonpolio enterovirus and human parechovirus surveillance - United States, 2006–2008. MMWR Morb Mortal Wkly Report. 2010;59:1577–1580.
4. Dagan R, Jenista JA, Menegus MA. Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infection. J Pediatr. 1988;113:975–978.
5. Tseng FC, Huang HC, Chi CY, et al. Epidemiological survey of enterovirus infections occurring in Taiwan between 2000 and 2005: analysis of sentinel physician surveillance data. J Med Virol. 2007;79:1850–1860.
6. Isacsohn M, Eidelman AI, Kaplan M, et al. Neonatal coxsackievirus group B infections: experience of a single department of neonatology. Isr J Med Sci. 1994;30:371–374.
7. Tryfonos C, Richter J, Koptides D, et al. Molecular typing and epidemiology of enteroviruses in Cyprus, 2003–2007. J Med Microbiol. 2011;60:1433–1440.
8. Sharp J, Harrison CJ, Puckett K, et al. Characteristics of young infants in whom human parechovirus, enterovirus or neither were detected in cerebrospinal fluid during sepsis evaluations. Pediatr Infect Dis J. 2013;32:213–216.
9. Harvala H, Griffiths M, Solomon T, et al. Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children. J Infect. 2014;69:69–74.
10. Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308–318.
11. Volle R, Bailly JL, Mirand A, et al. Variations in cerebrospinal fluid viral loads among enterovirus genotypes in patients hospitalized with laboratory-confirmed meningitis due to enterovirus. J Infect Dis. 2014;210:576–584.
12. Janes VA, Minnaar R, Koen G, et al. Presence of human non-polio enterovirus and parechovirus genotypes in an Amsterdam hospital in 2007 to 2011 compared to national and international published surveillance data: a comprehensive review. Euro Surveill. 2014;19.
13. Lee MK, Chan PK, Ho II, et al. Enterovirus infection among patients admitted to hospital in Hong Kong in 2010: epidemiology, clinical characteristics, and importance of molecular diagnosis. J Med Virol. 2013;85:1811–1817.
14. Antona D, Leveque N, Chomel JJ, et al. Surveillance of enteroviruses in France, 2000–2004. Eur J Clin Microbiol Infect Dis. 2007;26:403–412.
15. van der Sanden SM, Koopmans MP, et al. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011. Eur J Clin Microbiol Infect Dis. 2013;32:1525–1531.
16. Kadambari S, Bukasa A, Okike IO, et al. Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. Clin Microbiol Infect. 2014;20:1289–1296.
17. Iturriza-Gómara M, Megson B, Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006;78:243–253.
18. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.
19. Miyake CY, Teele SA, Chen L, et al. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014;113:535–540.
20. Shen WC, Chiu HH, Chow KC, et al. MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 1999;20:1889–1895.
21. Kestenbaum LA, Ebberson J, Zorc JJ, et al. Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants. Pediatrics. 2010;125:257–264.
22. Tebruegge M, Pantazidou A, Clifford V, et al. The age-related risk of co-existing meningitis in children with urinary tract infection. PLoS One. 2011;6:e26576.
23. Freund MW, Kleinveld G, Krediet TG, et al. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed. 2010;95:F206–12.
24. Verboon-Maciolek MA, Nijhuis M, van Loon AM, et al. Diagnosis of enterovirus infection in the first 2 months of life by real-time polymerase chain reaction. Clin Infect Dis. 2003;37:1–6.
25. Bryant PA, Tingay D, Dargaville PA, et al. Neonatal coxsackie B virus infection-a treatable disease? Eur J Pediatr. 2004;163:223–228.
26. Abzug MJ. The enteroviruses: problems in need of treatments. J Infect. 2014;68(Suppl 1):S108–S114.
27. Grist NR, Reid D. Organisms in myocarditis/endocarditis viruses. J Infect. 1997;34:155.
28. Nougairede A, Bessaud M, Thiberville SD, et al. Widespread circulation of a new echovirus 30 variant causing aseptic meningitis and non-specific viral illness, South-East France, 2013. J Clin Virol. 2014;61:118–124.
29. Maguire HC, Atkinson P, Sharland M, et al. Enterovirus infections in England and Wales: laboratory surveillance data: 1975 to 1994. Commun Dis Public Health. 1999;2:122–125.
30. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835–844.
enterovirus; myocarditis; sepsis; meningitis; encephalitisCopyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.